Conditions: Diabetes Mellitus
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 29
Healthy volunteers: no

Brief summary:
After 24 weeks of treatment evaluate the efficacy and security.

Detailed description:

Arms:
arm 1: sitagliptin

Interventions: intervention 1: sitagliptin phosphate
Intervention descriptions: intervention 1: Patients will receive sitagliptin with metformin for 24 weeks, given as oral tablets

Protocol document: